Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BAXTER INTERNATIONAL INC.

(BAX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/19/2021 07/20/2021 07/21/2021 07/22/2021 07/23/2021 Date
80.27(c) 80.54(c) 80.27(c) 80.51(c) 81.14(c) Last
3 108 616 2 108 092 1 769 882 874 597 1 826 709 Volume
-1.41% +0.34% -0.34% +0.30% +0.78% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 12 664 M - -
Net income 2021 1 636 M - -
Net Debt 2021 2 248 M - -
P/E ratio 2021 26,7x
Yield 2021 1,26%
Sales 2022 13 310 M - -
Net income 2022 1 931 M - -
Net Debt 2022 1 918 M - -
P/E ratio 2022 21,6x
Yield 2022 1,39%
Capitalization 40 801 M 40 801 M -
EV / Sales 2021 3,40x
EV / Sales 2022 3,21x
Nbr of Employees 50 000
Free-Float 73,4%
More Financials
Company
Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition... 
More about the company
Ratings of Baxter International Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about BAXTER INTERNATIONAL INC.
07/20BAXTER INTERNATIONAL : Engineered to Excel
PU
07/15BAXTER INTERNATIONAL : Funded Analysis Shows Active Hemostatic Products Lower Bl..
MT
07/15BAXTER INTERNATIONAL : Supports Analysis Demonstrating Clinical and Economic Ben..
BU
07/12BAXTER INTERNATIONAL : Declares Quarterly Dividend
BU
07/12Baxter International Inc. Declares Quarterly Cash Dividend, Payable on Octobe..
CI
07/08BAXTER INTERNATIONAL : Launches 2030 Corporate Responsibility Commitment to Adva..
PU
07/08BAXTER INTERNATIONAL : Launches New 2030 Corporate Responsibility Commitment to ..
BU
07/05BAXTER INTERNATIONAL : 2020 SASB Index
PU
06/29BAXTER INTERNATIONAL : Announces $1.2 Million in New Scholarships and Grant Fund..
BU
06/25BAXTER INTERNATIONAL INC.(NYSE : BAX) dropped from Russell 3000 Growth Index
CI
06/25BAXTER INTERNATIONAL INC.(NYSE : BAX) dropped from Russell 3000E Growth Index
CI
06/25BAXTER INTERNATIONAL INC.(NYSE : BAX) dropped from Russell 1000 Growth-Defensive..
CI
06/25BAXTER INTERNATIONAL INC.(NYSE : BAX) dropped from Russell 1000 Dynamic Index
CI
06/25BAXTER INTERNATIONAL INC.(NYSE : BAX) dropped from Russell 1000 Growth Index
CI
06/25BAXTER INTERNATIONAL INC.(NYSE : BAX) dropped from Russell Top 200 Growth Index
CI
More news
News in other languages on BAXTER INTERNATIONAL INC.
06/30IRW-PRESS : Sernova Corp. : Sernova verpflichtet Branchenveteran Frank Shannon a..
04/27DGAP-NEWS : MIG AG verzeichnet 2020 bestes Jahr der Unternehmensgeschichte und s..
03/15HINTERGRUND/Biontech formt globale Allianz für mehr Corona-Impfstoff
03/08MODERNA : Baxter International va aider à fabriquer le vaccin
02/23Farmacéuticas rivales se unen para fabricar más vacunas de Covid-19
More news
Analyst Recommendations on BAXTER INTERNATIONAL INC.
More recommendations
Chart BAXTER INTERNATIONAL INC.
Duration : Period :
Baxter International Inc. Technical Analysis Chart | BAX | US0718131099 | MarketScreener
Technical analysis trends BAXTER INTERNATIONAL INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 81,14 $
Average target price 93,41 $
Spread / Average Target 15,1%
EPS Revisions
Managers and Directors
José E. Almeida Chairman, President & Chief Executive Officer
James K. Saccaro Chief Financial Officer & Executive Vice President
Sumant Ramachandra Senior VP, Chief Science & Technology Officer
Tobi Karchmer Vice President-Worldwide Medical
Talvis Love Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
BAXTER INTERNATIONAL INC.1.12%41 329
ABBOTT LABORATORIES10.33%200 283
MEDTRONIC PLC9.73%168 081
BECTON, DICKINSON AND COMPANY0.34%70 145
HOYA CORPORATION3.33%50 251
ALIGN TECHNOLOGY, INC.19.44%48 667